PATENT CLAIM ANALYSIS

Application Number: 15745714
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["549", "022000"]

Abstract:
The invention relates to Pro-drugs, comprising red-ox-sensitive cleavage sites. The compounds may be utilized in medical practice for targeting of si RNA, antisense oligonucleotides or protein-based therapeutics to the cytoplasmatic compartment of cells both in vitro or in vivo, in a subject in need.

Claim (Index 10):
A Pro-drug according to  claim 1 , wherein either Y or Z, or both Y and Z comprise a drug, selected from a small-molecule drug, a peptide, a therapeutic protein and an oligonucleotide, selected from single-stranded or double-stranded RNA, DNA, siRNA or ASO.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.28947
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15691821', '15222559', '14872179', '14830799', '10585928']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7546240088802967
- 35 USC 102 Novelty (BERT): 0.5159932345578899
- Combined Prediction Score: 0.730760931448056
- Mean Citation Score: 271.216316
- Max Citation Score: 300.4459
- Similarity Product: 216.50115706161856

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test